Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc.（CATX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CATX · 截至 2026年6月9日
活动摘要
买入笔数
8
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Perspective Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CATX 季度内部人买卖趋势
CATX 内幕交易卖出 · CATX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CATX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CATX 高管卖出股份 · CATX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Nov 13, 2025 | Hunt Jonathan Robert CAO | Purchase | 11,000 | $22K | Form 4 |
| Nov 12, 2025 | Williamson Robert F III Director | Purchase | 9,498 | $20K | Form 4 |
| Mar 28, 2025 | Spoor Johan M. CEO · Director | Purchase | 22,026 | $49K | Form 4 |
| Mar 28, 2025 | Spoor Johan M. CEO · Director | Purchase | 4,650 | $10K | Form 4 |
| Mar 31, 2025 | Williamson Robert F III Director | Purchase | 38,145 | $82K | Form 4 |
| Mar 28, 2025 | Williamson Robert F III Director | Purchase | 22,192 | $50K | Form 4 |
| Mar 28, 2025 | Graham Juan CFO | Purchase | 33,333 | $75K | Form 4 |
| Mar 31, 2025 | Woods Lori A Director | Purchase | 23,475 | $50K | Form 4 |
| Dec 4, 2024 | HENSON HEIDI Director | Purchase | 25,975 | $100K | Form 4 |
| Dec 4, 2024 | Spoor Johan M. CEO · Director | Purchase | 8,000 | $30K | Form 4 |
| Nov 25, 2024 | Williamson Robert F III Director | Purchase | 2,619 | $10K | Form 4 |
| Nov 25, 2024 | Williamson Robert F III Director | Purchase | 3,647 | $13K | Form 4 |
| Nov 25, 2024 | Hunt Jonathan Robert CFO | Purchase | 10,000 | $39K | Form 4 |
| Nov 25, 2024 | Hunt Jonathan Robert CFO | Purchase | 2,400 | $9K | Form 4 |
| Nov 25, 2024 | Hunt Jonathan Robert CFO | Purchase | 29 | $114 | Form 4 |
| Nov 25, 2024 | Hunt Jonathan Robert CFO | Purchase | 400 | $1K | Form 4 |
| Nov 25, 2024 | Spoor Johan M. CEO · Director | Purchase | 14,500 | $55K | Form 4 |
| Nov 25, 2024 | Spoor Johan M. CEO · Director | Purchase | 6,600 | $25K | Form 4 |
| Nov 25, 2024 | Spoor Johan M. CEO · Director | Purchase | 5,400 | $21K | Form 4 |
| Jun 17, 2024 | Hunt Jonathan Robert CFO | Purchase | 1,800 | $18K | Form 4 |
| Jun 14, 2024 | Woods Lori A Director | Purchase | 83 | $896 | Form 4 |
| Jun 14, 2024 | Woods Lori A Director | Purchase | 4,504 | $49K | Form 4 |
| Jun 13, 2024 | Spoor Johan M. CEO · Director | Purchase | 100,000 | $117K | Form 4 |
| Jun 3, 2024 | Woods Lori A Director | Purchase | 34,246 | $50K | Form 4 |
| May 31, 2024 | Hunt Jonathan Robert CFO | Purchase | 12,000 | $17K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CATX 内幕交易
CATX 内幕交易
Perspective Therapeutics, Inc.（CATX）内幕交易数据来源于公司内部人（包括Hunt Jonathan Robert (CAO), Williamson Robert F III (Director)）提交的SEC Form 4申报文件。过去12个月内，2位内部人向SEC提交了交易申报。CATX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Perspective Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CATX 内幕交易 · 5个问题Perspective Therapeutics, Inc.（CATX）的内部人包括高管和董事，如Hunt Jonathan Robert (CAO), Williamson Robert F III (Director)等。过去12个月内，2位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026